Pardes Biosciences, Inc.

Ownership Transactions Reported by 22 Insiders

Industry
Pharmaceutical Preparations
Location
2173 Salk Avenue, Suite 250, Pmb#052, Carlsbad, California

There are no Buy or Sell transactions made by insiders since 7/17/2023

Pardes Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Foresite Capital Management V, LLC 10%+ Owner $20.4 M Apr 5, 2023
Foresite Capital Opportunity Management V, LLC 10%+ Owner $13.2 M Apr 5, 2023
FS Development Holdings II, LLC 10%+ Owner $7.31 M Dec 23, 2021
Lee D. Arnold Chief Scientific Officer $4.22 M Feb 1, 2022
Sean P. Brusky Chief Commercial Officer $31.5 K Feb 1, 2023
James B. Tananbaum President and CEO, Director, 10%+ Owner $1.5 K Aug 31, 2023
H. Lacy General Counsel, Secretary Aug 31, 2023
Mark Auerbach Director Aug 31, 2023
J. Jay Lobell Director Aug 31, 2023
Laura Hamill Director Aug 31, 2023
John C. Pottage Jr Director Aug 31, 2023
Owen Hughes Director Dec 23, 2021
Deepika Pakianathan Director Dec 23, 2021
Brian Philippe Tinmouth Chief Bus. & Strategy Officer Sep 14, 2022
Heidi Henson Chief Financial Officer Aug 31, 2023
Thomas G. Wiggans Chief Executive Officer, Director Aug 31, 2023
Uri A. Lopatin Director Aug 31, 2023
Laurie Smaldone Director Aug 31, 2023
Michael David Varney Director Aug 31, 2023
Deborah M. Autor Director Aug 31, 2023
Daniel Dubin Director Dec 23, 2021
Brian Kearney Chief Development Officer Feb 1, 2023

Recent Insider Transactions by Companies or Individuals for Pardes Biosciences, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership